OTC & Nutraceuticals US

US Insulin Resistance Supplements Market Analysis, 2024–2034

US Insulin Resistance Supplements Market Industry Trends and Forecast to 2034: Segmented by (Ingredient, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $766.3 Mn Estimated value
Estimate 2025 $817.7 Mn 43% of the global market
Projected 2034 $1.47 Bn 79.3% Adds $648.1 Mn over 9 forecast years
CAGR 2025–2034 6.7% Faster than 82% of 82 OTC & Nutraceuticals markets here
Key players 5
  • US is 43.01% of the global market.
  • In North America, the largest is US (this report) at $817.7 Mn.
  • Fastest growing: Canada at 8.6% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$648.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Insulin Resistance Supplements Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $766.3 Mn — —
2025 (base) $817.7 Mn +$51.3 Mn —
2026 (forecast) $872.4 Mn +$54.8 Mn +6.7%
2027 (forecast) $930.9 Mn +$58.5 Mn +13.8%
2028 (forecast) $993.3 Mn +$62.4 Mn +21.5%
2029 (forecast) $1.06 Bn +$66.5 Mn +29.6%
2030 (forecast) $1.13 Bn +$71.0 Mn +38.3%
2031 (forecast) $1.21 Bn +$75.8 Mn +47.6%
2032 (forecast) $1.29 Bn +$80.8 Mn +57.5%
2033 (forecast) $1.37 Bn +$86.3 Mn +68%
2034 (forecast) $1.47 Bn +$92.0 Mn +79.3%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.90 Bn
  2. North America $973.1 Mn
  3. US (this report) $817.7 Mn
  4. APAC $468.3 Mn
  5. Europe $354.8 Mn
  6. China $178.7 Mn
  7. Canada $147.0 Mn
  8. Japan $122.6 Mn
  9. Latin America $92.6 Mn
  10. Middle East $70.5 Mn
  11. Germany $63.5 Mn
  12. France $54.2 Mn
  13. UK $52.9 Mn
  14. Italy $49.8 Mn
  15. Brazil $49.8 Mn
  16. Spain $39.9 Mn
  17. Ecuador $36.0 Mn
  18. Saudi Arabia $35.3 Mn
  19. Africa $33.5 Mn
  20. Mexico $32.1 Mn
  21. India $31.6 Mn
  22. Australia $25.6 Mn
  23. Russia $21.5 Mn
  24. New Zealand $18.5 Mn
  25. South Africa $13.8 Mn
  26. UAE $8.7 Mn
  27. Egypt $6.1 Mn
  28. Philippines $4.8 Mn
  29. Hong Kong $3.3 Mn
  30. Malaysia $3.2 Mn
  31. Singapore $2.3 Mn
  32. Thailand $2.3 Mn
  33. Kenya $1.4 Mn

The US Insulin Resistance Supplements Market Analysis Executive Summary

Insulin resistance supplements contain ingredients such as berberine, inositol, chromium and cinnamon that claim to support healthy blood sugar.

Key segments of the insulin Resistance Supplements market include ingredient (Berberine, Inositol and Chromium) and form (Capsules, Powders and Gummies).

US Insulin Resistance Supplements Market Dynamics

Market Growth Drivers

Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the insulin Resistance Supplements market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.

Opportunity

Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the insulin Resistance Supplements market, especially in fast-growing emerging economies.

Market Restraints

High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the insulin Resistance Supplements market. Long-term safety data and lifestyle support are still needed for many patients.

Competitive Landscape for Insulin Resistance Supplements Market in US

The insulin Resistance Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Insulin Resistance Supplements Market in US

Policy changes and Reimbursement scenario

Food and supplement rules, labelling and health-claim regulations govern insulin Resistance Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in US.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Insulin Resistance Supplements right now, from free public sources.

Clinical trials

143 active trials in the US

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Hangzhou Sciwind Biosciences Co., Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Signos 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Latest research 2,843 papers since 2021 (worldwide)

  1. Sleep and circadian disruption as systemic drivers of breast cancer metastasis: A tri-pathway mechanistic model. Biochemical pharmacology, 2026
  2. Vitamin E in diabetes-associated cognitive dysfunction: mechanistic rationale, current evidence and translational gaps. Frontiers in nutrition, 2026
  3. ROS-Responsive Selenocysteine-Releasing Nanozyme for Targeted Ferroptosis Suppression and Pancreatic β-Cell Protection in Type 2 Diabetes. Nano letters, 2026
  4. Effect of vitamin D supplementation on metabolic syndrome parameters in adults: a systematic review of randomized controlled trials exploring the role of baseline vitamin D status and supplementation dose. Frontiers in nutrition, 2026
  5. Targeting inflammation during chronic heat stress improved intramuscular heat shock protein 70, myoblast differentiation, and muscle growth in finishing lambs. Journal of animal science, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Insulin Resistance Supplements in context

The US compared

  • Diabetes (adults, WHO): 12.5% of adults (2022). World: 14.1% of adults (2022).[1]
  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[2]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[3]

Questions, answered with public data

How many clinical trials on Insulin Resistance Supplements are running in the US?
143 studies are recruiting, active or about to start in the US.[4]
How much research is published on Insulin Resistance Supplements?
PubMed lists 2,843 papers added since January 2021 that match this market, worldwide.[5]
What does WHO report for the US?
Diabetes (adults, WHO): 12.5 % of adults in 2022, the latest WHO figure.[1]
How many people in the US are 65 or older?
18.4% of people were 65 or older in 2025.[6]

[1] WHO Global Health Observatory, Diabetes (adults, WHO) (% of adults). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.

[5] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

[6] World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 13 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Insulin Resistance Supplements in US? Our analysts can size it for your plan. Talk to us See the public data Diabetes (adults, WHO) for every country, free. Open the Public Health Dashboard

From our blog

Bone and Joint Health: Supplements for an Ageing Population1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence… Eye Health Supplements: Screens, Ageing and Vision2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a… Herbal Supplements: Quality, Safety and Trust170 of 194 WHO member states report use of traditional medicine. Herbal products are popular, but quality and…
Back to Catalogue
Keep exploring

Related OTC & Nutraceuticals reports in US

See all
Same topic, other categories

Related on diabetes and nutrition

See the topic